Li Li-xian, Chen Li, Zhao Huan-jia
Emergency Department of Higher Education Mega Center Hospital, Guangdong Provintial Hospital of Chinese Medicine, Guangzhou.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Dec;31(12):1615-8.
To observe the effect of Naoxintong Capsule (NC) on the vascular endothelial function and the infarct size of patients with acute myocardial infarction (AMI).
One hundred and four patients with AMI were randomly assigned to the NC group (Group A, 36 cases), the Tongguan Capsule group (Group B, 32 cases), and the conventional Western medicine group (Group C, 36 cases). The conventional Western medicine was given to the three groups. NC was additionally given to Group A, and Tongguan Capsule was additionally given to Group B. The therapeutic course for all was 4 weeks. The plasma nitric oxide (NO), endothelin (ET), von Willebrand factor (vWF) were detected in the 3 groups before and after treatment. The inner diameter of brachial artery was examined by ultrasonograph. The flow-mediated dilation (FMD) and the nitroglycerin-mediated dilation (NMD) were calculated. The ECG QRS integral and the infarct size were assessed.
There was no significant difference in the vascular endothelial function, ECG QRS integral, or the infarct size among the three groups before treatment (P > 0.05). Compared with before treatment, NO and NMD obviously increased after treatment in Group A and Group B, while the vWF and the infarct size obviously decreased in Group A, all showing statistical difference (P < 0.05). Compared with those in Group C, the NO, FMD, NMD significantly increased and ET obviously decreased in Group A and B after treatment (P < 0.05). The ECG QRS integral and the infarct size also decreased, with statistically significant differences in Group A (P < 0.05). Better effects on improving NO, NMD, and vWF were obtained in Group A than in Group B (P < 0.05).
NC could reduce the infarct size of AMI patients possibly through improving the vascular endothelial function.
观察脑心通胶囊(NC)对急性心肌梗死(AMI)患者血管内皮功能及梗死面积的影响。
将104例AMI患者随机分为NC组(A组,36例)、通冠胶囊组(B组,32例)和西医常规治疗组(C组,36例)。三组均给予西医常规治疗,A组加用NC,B组加用通冠胶囊。疗程均为4周。检测三组治疗前后血浆一氧化氮(NO)、内皮素(ET)、血管性血友病因子(vWF)水平,采用超声仪检测肱动脉内径,计算血流介导的血管舒张功能(FMD)和硝酸甘油介导的血管舒张功能(NMD),评估心电图QRS积分及梗死面积。
治疗前三组血管内皮功能、心电图QRS积分及梗死面积比较,差异无统计学意义(P>0.05)。治疗后,A组和B组NO、NMD较治疗前明显升高,A组vWF及梗死面积明显降低,差异均有统计学意义(P<0.05)。治疗后,A组和B组NO、FMD、NMD较C组明显升高,ET明显降低(P<0.05),心电图QRS积分及梗死面积亦降低,A组差异有统计学意义(P<0.05)。A组改善NO、NMD及vWF的效果优于B组(P<0.05)。
脑心通胶囊可能通过改善血管内皮功能而减小AMI患者的梗死面积。